Strategic Growth Target hospitals and spine centers expanding into anterior and lateral lumbar fusion procedures, leveraging Spinal Elements Ventana 3D-Printed Interbody Portfolio and the new Ventana A ALIF system to position as a primary technology provider for next generation spine constructs.

Regulatory Momentum Capitalize on FDA 510(k) clearance for the Ventana A ALIF system to accelerate adoption efforts, focusing on surgeon training, key opinion leader engagement, and formal evidence generation to shorten time-to-implant and expand placement.

Product Reach Explore cross-selling opportunities by pairing advanced implants with complementary biologics and instrumentation from Spinal Elements, enabling integrated solutions for complex spine surgeries and differentiating from incumbents.

Strategic Partnerships Engage with major spine centers, distributors, and regional groups highlighted by recent conference presence and publications to establish preferred supplier status and channel partnerships that broaden market access.

Market Position Position Spinal Elements as a growth-focused innovator in mid-market spine devices competing with mid-sized peers; emphasize rapid product launches like Ventana portfolios to win share against similar-yield suppliers in the $25M–$50M revenue segment.